Skip to content
Setcoin Group
Request access
Chapter 15 of 92Space & aerospace2 min read · 0 exhibits

Case Study: Lilly, Insulin and Automated Crystallisation

What has Eli Lilly's work with Redwire's PIL-BOX shown, and what does automation change?

Chapter summary

Lilly has used Redwire's Pharmaceutical In-space Laboratory (PIL-BOX), an automated crystallisation cassette on the ISS, to grow crystals of small molecules for diabetes, cardiovascular disease and pain research, and earlier work showed insulin crystals grown in microgravity were larger and more ordered than ground crystals.

Key takeaways

  1. 1

    Redwire has returned several batches of crystals for Lilly and others, and a March 2026 NASA funding announcement for Redwire's drug development work named Lilly and Bristol Myers Squibb among partners.

  2. 2

    The case shows large pharma using automated hardware for repeated campaigns, the pattern most likely to grow on capsules.

Space access

Keep reading with Space access

This chapter (359 words) is part of Space & aerospace. Space access opens every chapter of all 11 Space reports, with the interactive models, Excel downloads, Ask and named Atlas records.

  • Global Market Analysis: Deep Space Economy
  • Space-Based Datacenters: Feasibility Study
  • Commercial Space Stations: Feasibility Study
  • Defence Space and Missile Defence: Golden Dome and the SDA Architecture
  • Launch After Starship: Prices, Capacity and European Sovereign Launch, 2026–2035
  • Satellites to Phones: Direct-to-Device Connectivity, Spectrum and Economics, 2026–2035
  • Space Supply Chain Bottlenecks: Components, Minerals and Capacity, 2026–2030
  • Lunar, Cislunar and Settlement Economics: What the Moon Costs and Who Pays, 2026–2060
  • Earth Observation and AI Analytics: What a Square Kilometre Is Worth and Who Captures It, 2026–2035
  • In-Space Manufacturing and Microgravity Biotech: Products, Platforms and Economics, 2026–2035
  • Space-Based Solar Power: Physics, Costs and the Path to Firm Power from Orbit, 2026–2050

€199 a month or €1,490 a year per sector, after a 7-day free trial. Cancel any time. Need several sectors? All sectors: €999 a month.

Check the live record Space Contracts & Tender Radar · Space Claim Check (free)

Ask about this chapter

Answers drawn from every Setcoin report and the live Atlas. Each statement links to the passage behind it.

Summarise "Case Study: Lilly, Insulin and Automated Crystallisation" in five pointsWhich figures in this chapter matter most to an investment committee?What should I check on the Atlas after reading this?
Subscription

Ask is included with every subscription

Cited answers across every report and the Atlas, with follow-up questions and a hand-off to the opportunity finder.

Research for professional investors. Not investment advice, and not an offer of any security or fund interest.